Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
UBS
Farmers Insurance
Cerilliant
AstraZeneca
Federal Trade Commission
Chubb
Queensland Health
Citi
McKesson

Generated: February 21, 2018

DrugPatentWatch Database Preview

TETREX Drug Profile

« Back to Dashboard

Which patents cover Tetrex, and when can generic versions of Tetrex launch?

Tetrex is a drug marketed by Bristol and is included in three NDAs.

The generic ingredient in TETREX is tetracycline phosphate complex. There are ninety-nine drug master file entries for this compound. Additional details are available on the tetracycline phosphate complex profile page.

US Patents and Regulatory Information for TETREX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol TETREX tetracycline phosphate complex CAPSULE;ORAL 061653-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol TETREX tetracycline phosphate complex CAPSULE;ORAL 050212-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol TETREX tetracycline phosphate complex CAPSULE;ORAL 050212-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol TETREX tetracycline phosphate complex CAPSULE;ORAL 061653-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol TETREX tetracycline phosphate complex CAPSULE;ORAL 061889-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol TETREX tetracycline phosphate complex CAPSULE;ORAL 061889-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol TETREX tetracycline phosphate complex CAPSULE;ORAL 061653-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Harvard Business School
Farmers Insurance
Teva
QuintilesIMS
Chubb
Johnson and Johnson
Healthtrust
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot